BioSenic SA — Board/Management Information 2019

May 10, 2019

Thomas Lienard

Thomas has over 15 years of national and international sales and marketing experience in the pharmaceutical industry.

Prior to joining Bone Therapeutics, Thomas worked at Lundbeck, where he acted as Managing Director for Belgium and Luxemburg and was vital to the launch of several products. Before this, he worked at Eli Lilly and Company, where he held various positions in sales and marketing in Europe and the US. Thomas started his career in 1999 as consultant at McKinsey & Company. He graduated from Solvay Brussels School of Economics and Management as Master in Business Engineering in 1999 and obtained a Master of Business Administration (MBA) from Harvard Business School in Boston in 2004.

Thomas joined Bone Therapeutics in 2015 as Chief Business Officer in charge of activities related to business development and strategic planning, and was appointed CEO in October 2016.